GI
COGT icon

GAMMA Investing’s Cogent Biosciences COGT Stock Holding History

GAMMA Investing’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40.5K Sell
1,266
-37
-3% -$1.37K ﹤0.01% 2517
2026
Q2 		$50.4K Buy
1,303
+143
+12% +$5K ﹤0.01% 2289
2026
Q1 		$44.6K Sell
1,160
-209
-15% -$7.72K ﹤0.01% 2252
2025
Q4 		$48.6K Buy
1,369
+655
+92% +$18.4K ﹤0.01% 2094
2025
Q3 		$10.3K Buy
714
+412
+136% +$4.88K ﹤0.01% 2870
2025
Q2 		$2.17K Sell
302
-208
-41% -$1.15K ﹤0.01% 3381
2025
Q1 		$3.06K Buy
510
+147
+40% +$1.15K ﹤0.01% 3266
2024
Q4 		$2.83K Sell
363
-211
-37% -$2.1K ﹤0.01% 3112
2024
Q3 		$6.2K Buy
574
+452
+370% +$4.4K ﹤0.01% 2665
2024
Q2 		$1.03K Sell
122
-12
-9% -$91 ﹤0.01% 3055
2024
Q1 		$900 Sell
134
-77
-36% -$476 ﹤0.01% 2964
2023
Q4 		$935 Buy
+211
New +$1.62K ﹤0.01% 2809

Other funds holding COGT

AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's COGT Position: Q3 2026 in Review

GAMMA Investing reduced its Cogent Biosciences (COGT) stake by 2.8% in Q3 2026, selling an estimated $1.37K and leaving 1,266 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

GAMMA Investing first reported a position in COGT in Q4 2023 and has held it in 12 quarters since. The position peaked at $50.4K in Q2 2026. 6 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • GAMMA Investing held 1,266 shares of Cogent Biosciences worth $40.5K as of Q3 2026.
  • GAMMA Investing sold 37 Cogent Biosciences shares in Q3 2026, an estimated $1.37K.
  • Cogent Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2517 holding.
  • GAMMA Investing first reported a position in Cogent Biosciences in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Cogent Biosciences position peaked at $50.4K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.